P2.12-15 Prognostic and Predictive Covariates in Limited-Stage Small-Cell Lung Cancer: Analysis of the Phase 3 CONVERT Trial

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.1391
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

P2.12-10 Novel Prognostic Model for Limited-Stage Small-Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

OA13.05 Prophylactic Cranial Irradiation (PCI) for Limited-Stage Small-Cell Lung Cancer: Results From the Phase 3 CONVERT Trial

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Prophylactic Cranial Irradiation for Limited-Stage Small-Cell Lung Cancer Patients: Secondary Findings From the Prospective Randomized Phase 3 CONVERT Trial

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2019English

OA13.01 the Impact of [18F]fludeoxyglucose PET/CT in Small-Cell Lung Cancer: Analysis of the Phase 3 CONVERT Trial

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

[18F]fludeoxyglucose PET/CT in Small-Cell Lung Cancer: Analysis of the CONVERT Randomized Controlled Trial

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2019English

Progress in the Management of Limited-Stage Small Cell Lung Cancer

Cancer
Cancer ResearchOncology
2013English

P2.12-18 Interstitial Lung Abnormalities Are a Risk Factor for Radiation Pneumonitis in Patients With Limited-Stage Small-Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Tumor Lysis Syndrome in Limited-Stage Small-Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2013English

P2.12-03 Phase I/Ii Trial of 177Lu-Dota0-Tyr3-Octreotate (Lutathera) and Nivolumab for Patients With Extensive-Stage Small Cell Lung Cancer (ES-SCLC)

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy